These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 18599612)

  • 1. Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy.
    Van Vickle GD; Esh CL; Daugs ID; Kokjohn TA; Kalback WM; Patton RL; Luehrs DC; Walker DG; Lue LF; Beach TG; Davis J; Van Nostrand WE; Castaño EM; Roher AE
    Am J Pathol; 2008 Aug; 173(2):483-93. PubMed ID: 18599612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice.
    Xu F; Vitek MP; Colton CA; Previti ML; Gharkholonarehe N; Davis J; Van Nostrand WE
    J Neurosci; 2008 May; 28(20):5312-20. PubMed ID: 18480287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice.
    Xu F; Kotarba AE; Ou-Yang MH; Fu Z; Davis J; Smith SO; Van Nostrand WE
    J Biol Chem; 2014 Jun; 289(25):17895-908. PubMed ID: 24828504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor.
    Davis J; Xu F; Deane R; Romanov G; Previti ML; Zeigler K; Zlokovic BV; Van Nostrand WE
    J Biol Chem; 2004 May; 279(19):20296-306. PubMed ID: 14985348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human apolipoprotein E2 promotes parenchymal amyloid deposition and neuronal loss in vasculotropic mutant amyloid-β protein Tg-SwDI mice.
    Xu F; Vitek MP; Colton CA; Previti ML; Davis J; Van Nostrand WE
    J Alzheimers Dis; 2012; 31(2):359-69. PubMed ID: 22635103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy.
    Robison LS; Popescu DL; Anderson ME; Francis N; Hatfield J; Sullivan JK; Beigelman SI; Xu F; Anderson BJ; Van Nostrand WE; Robinson JK
    J Neuroinflammation; 2019 Jul; 16(1):144. PubMed ID: 31296239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE and AβPP gene variation in cortical and cerebrovascular amyloid-β pathology and Alzheimer's disease: a population-based analysis.
    Peuralinna T; Tanskanen M; Mäkelä M; Polvikoski T; Paetau A; Kalimo H; Sulkava R; Hardy J; Lai SL; Arepalli S; Hernandez D; Traynor BJ; Singleton A; Tienari PJ; Myllykangas L
    J Alzheimers Dis; 2011; 26(2):377-85. PubMed ID: 21654062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc(CO)3-Labeled Benzothiazole Derivatives Preferentially Bind Cerebrovascular Amyloid: Potential Use as Imaging Agents for Cerebral Amyloid Angiopathy.
    Jia J; Cui M; Dai J; Liu B
    Mol Pharm; 2015 Aug; 12(8):2937-46. PubMed ID: 26065726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
    Cho HS; Hyman BT; Greenberg SM; Rebeck GW
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-truncated Aβ2-X starting with position two in sporadic Alzheimer's disease cases and two Alzheimer mouse models.
    Savastano A; Klafki H; Haußmann U; Oberstein TJ; Muller P; Wirths O; Wiltfang J; Bayer TA
    J Alzheimers Dis; 2016; 49(1):101-10. PubMed ID: 26529393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model.
    Huynh TV; Wang C; Tran AC; Tabor GT; Mahan TE; Francis CM; Finn MB; Spellman R; Manis M; Tanzi RE; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2019 Oct; 14(1):37. PubMed ID: 31623648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent Age-Dependent Conformational Rearrangement within Aβ Amyloid Deposits in APP23, APPPS1, and
    Parvin F; Haglund S; Wegenast-Braun B; Jucker M; Saito T; Saido TC; Nilsson KPR; Nilsson P; Nyström S; Hammarström P
    ACS Chem Neurosci; 2024 May; 15(10):2058-2069. PubMed ID: 38652895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic cerebral hypoperfusion alters amyloid-β peptide pools leading to cerebral amyloid angiopathy, microinfarcts and haemorrhages in Tg-SwDI mice.
    Salvadores N; Searcy JL; Holland PR; Horsburgh K
    Clin Sci (Lond); 2017 Aug; 131(16):2109-2123. PubMed ID: 28667120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy.
    Xiong M; Wang C; Gratuze M; Saadi F; Bao X; Bosch ME; Lee C; Jiang H; Serrano JR; Gonzales ER; Kipnis M; Holtzman DM
    Mol Neurodegener; 2023 Mar; 18(1):17. PubMed ID: 36922879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.
    Yang J; Ji Y; Mehta P; Bates KA; Sun Y; Wisniewski T
    J Alzheimers Dis; 2011; 24(2):269-85. PubMed ID: 21239853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.
    Frost JL; Le KX; Cynis H; Ekpo E; Kleinschmidt M; Palmour RM; Ervin FR; Snigdha S; Cotman CW; Saido TC; Vassar RJ; St George-Hyslop P; Ikezu T; Schilling S; Demuth HU; Lemere CA
    Am J Pathol; 2013 Aug; 183(2):369-81. PubMed ID: 23747948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.
    Xu G; Fromholt SE; Chakrabarty P; Zhu F; Liu X; Pace MC; Koh J; Golde TE; Levites Y; Lewis J; Borchelt DR
    Acta Neuropathol Commun; 2020 Apr; 8(1):43. PubMed ID: 32252825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.